# SHFH (Scientist Home Future Health Limited) - SEC EDGAR Financial Statements

> Scientist Home Future Health Limited reported $573K in revenue and a net loss of $344K for the trailing twelve months ended September 30, 2026 (up 435.3% year over year), with a 42.2% gross margin and a -60.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/SHFH
- Markdown: https://convexityos.com/fundamentals/SHFH.md
- SEC CIK: 0002032609
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002032609&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $573K | +435.3% YoY |
| Operating Income | TTM | -$344K | -60.1% margin |
| Net Income | TTM | -$344K | -60.1% net margin |
| Diluted EPS | TTM | -$0.01 | Split-adjusted |
| Free Cash Flow | TTM | -$323K | -56.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $333K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| **Revenue** | $204K |
| Cost of Revenue | $122K |
| **Gross Profit** | $82K |
| Selling, General & Admin | $314K |
| Total Operating Expenses | -$314K |
| **Operating Income** | -$232K |
| **EBITDA** | -$230K |
| Income Before Tax | -$232K |
| Income Tax Expense | $0 |
| **Net Income** | -$232K |
| **Diluted EPS** | -$0.01 |
| Diluted Shares Outstanding | 23.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $212K | $84K | $189K | $88K | $40K | $32K | $45K | -- |
| Cost of Revenue | $91K | $55K | $130K | $55K | $24K | $18K | $25K | -- |
| **Gross Profit** | $121K | $29K | $59K | $33K | $16K | $14K | $20K | -- |
| Selling, General & Admin | $113K | $127K | $161K | $185K | $64K | $52K | $13K | -- |
| Total Operating Expenses | -$113K | -$127K | -$161K | -$185K | -$64K | -$52K | -$13K | -- |
| **Operating Income** | $8.2K | -$98K | -$102K | -$153K | -$48K | -$38K | $7.0K | -- |
| **EBITDA** | $12K | -$94K | -$98K | -$151K | -$48K | -$38K | $7.0K | -- |
| Income Before Tax | $8.2K | -$98K | -$102K | -$153K | -$48K | -$38K | $7.0K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$935 | $935 | -- |
| **Net Income** | $8.2K | -$98K | -$102K | -$153K | -$48K | -$37K | $6.1K | -$15K |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted Shares Outstanding | 23.7M | 23.7M | 23.7M | -- | 23.7M | 23.5M | 23.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Inventory | $34K | $2.6K |
| **Total Current Assets** | $192K | $21K |
| Property, Plant & Equipment, Net | $73K | $0 |
| **Total Non-Current Assets** | $452K | $0 |
| **Total Assets** | $644K | $21K |
| **Total Current Liabilities** | $214K | $27K |
| **Total Non-Current Liabilities** | $317K | $0 |
| **Total Liabilities** | $531K | $27K |
| **Total Debt (incl. Leases)** | $391K | -- |
| Common Stock | $2.4K | $2.3K |
| Retained Earnings | -$247K | -$15K |
| Accumulated Other Comp. Income | -$2.9K | $0 |
| **Total Stockholders' Equity** | $113K | -$6.0K |
| Total Equity | $113K | -$6.0K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Inventory | $129K | $34K | $31K | $34K | $2.0K | $3.3K | $3.5K | $2.6K |
| **Total Current Assets** | $226K | $125K | $132K | $192K | $326K | $115K | $20K | $21K |
| Property, Plant & Equipment, Net | $61K | $65K | $69K | $73K | -- | $0 | -- | $0 |
| **Total Non-Current Assets** | $382K | $405K | $427K | $452K | $397K | $0 | $0 | $0 |
| **Total Assets** | $608K | $530K | $559K | $644K | $723K | $115K | $20K | $21K |
| **Total Current Liabilities** | $424K | $340K | $252K | $214K | $123K | $63K | $20K | $27K |
| **Total Non-Current Liabilities** | $262K | $276K | $295K | $317K | $333K | $0 | $0 | $0 |
| **Total Liabilities** | $686K | $616K | $547K | $531K | $456K | $63K | $20K | $27K |
| **Total Debt (incl. Leases)** | $333K | $351K | $370K | $391K | $400K | -- | -- | -- |
| Common Stock | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $2.3K | $2.3K |
| Retained Earnings | -$438K | -$447K | -$349K | -$247K | -$94K | -$46K | -$8.9K | -$15K |
| Accumulated Other Comp. Income | -$2.7K | -$2.7K | -$2.8K | -$2.9K | -$2.0K | $207 | -$12 | $0 |
| **Total Stockholders' Equity** | -$78K | -$86K | $11K | $113K | $267K | $52K | $27 | -$6.0K |
| Total Equity | -$78K | -$86K | $11K | $113K | $267K | $52K | $27 | -$6.0K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Net Income | -$232K |
| Depreciation & Amortization | $1.7K |
| Change in Inventory | -$31K |
| Change in Payables | $0 |
| **Operating Cash Flow** | -$248K |
| Capital Expenditure | -$75K |
| **Free Cash Flow** | -$323K |
| **Investing Cash Flow** | -$75K |
| Common Stock Issued | $354K |
| **Financing Cash Flow** | $376K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $8.2K | -$98K | -$102K | -$153K | -$48K | -$37K | $6.1K | -$15K |
| Depreciation & Amortization | $3.7K | $3.7K | $3.7K | $1.7K | $0 | $0 | $0 | -- |
| Change in Working Capital | -- | -- | $30K | -- | -- | -- | -$11K | -- |
| Change in Inventory | -$95K | -$2.5K | $2.4K | -$32K | $1.4K | $102 | -$826 | $1.8K |
| Change in Payables | $66K | $0 | $0 | -$50K | $50K | $0 | $0 | -- |
| **Operating Cash Flow** | -$45K | -$13K | -$72K | -$139K | -$99K | -$5.3K | -$4.8K | $8.7K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | $49K | $6.6K | $19K | $7.7K | $265K | $101K | $2.3K | -$9.0K |
| **Net Change in Cash** | $4.6K | -$6.3K | -$54K | -- | $164K | $95K | -$2.5K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 |
| --- | --- |
| **Gross Margin** | 40.1% |
| **Operating Margin** | -113.6% |
| **Net Profit Margin** | -113.6% |
| Return on Equity (ROE) | -204.4% |
| Return on Assets (ROA) | -36.0% |
| Current Ratio | 0.90x |
| Quick Ratio | 0.74x |
| Debt to Equity | 3.45x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 42.2% | 34.1% | 34.8% | 40.1% | -- | -- | -- | -- |
| **Operating Margin** | -60.1% | -99.9% | -97.9% | -113.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -60.1% | -99.9% | -97.7% | -113.6% | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -2974.1% | -204.4% | -35.3% | -89.5% | -- | -- |
| Return on Assets (ROA) | -56.7% | -75.6% | -60.8% | -36.0% | -13.0% | -40.2% | -- | -- |
| Current Ratio | 0.53x | 0.37x | 0.52x | 0.90x | 2.64x | 1.82x | 1.00x | 0.78x |
| Quick Ratio | 0.23x | 0.27x | 0.40x | 0.74x | 2.62x | 1.76x | 0.82x | 0.68x |
| Debt to Equity | -- | -- | 32.36x | 3.45x | 1.50x | -- | -- | -- |
| **Revenue Growth (YoY)** | +435.3% | +167.2% | +321.1% | -- | -33.3% | -- | -- | -- |
| Gross Profit Growth (YoY) | +653.1% | +115.0% | +200.0% | -- | -39.1% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -1559.4% | -- | -2581.6% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -1784.6% | -- | -27440.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -1698.9% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
